[Liver transplantation in metastatic neuroendocrine tumors. Symptom-free intervals and cure possible].
Ahlman
Håkan
H
Sahlgrenska Universitetssjukhuset, Göteborg. hakan.ahlman@surgery.gu.se
Olausson
Michael
M
Friman
Styrbjörn
S
Herlenius
Gustaf
G
Cahlin
Christian
C
Nilsson
Ola
O
Jansson
Svante
S
Wängberg
Bo
B
D000328:Adult; D014408:Biomarkers, Tumor / Q000032:analysis; D002276:Carcinoid Tumor / Q000401:mortality / Q000556:secondary / Q000601:surgery; D005260:Female; D006801:Humans; D008113:Liver Neoplasms / Q000401:mortality / Q000556:secondary / Q000601:surgery*; D016031:Liver Transplantation / Q000379:methods; D008297:Male; D008875:Middle Aged; D009364:Neoplasm Recurrence, Local / Q000175:diagnosis; D018358:Neuroendocrine Tumors / Q000401:mortality / Q000556:secondary / Q000601:surgery*; D010190:Pancreatic Neoplasms / Q000401:mortality / Q000556:secondary / Q000601:surgery; D012307:Risk Factors; D016019:Survival Analysis; D014057:Tomography, X-Ray Computed; D016896:Treatment Outcome
D014408:Biomarkers, Tumor